Aimei Health Technology (AFJK) EBITDA (2024 - 2025)
Aimei Health Technology (AFJK) reported EBITDA of -$130152.0 for Q3 2025, up 34.93% year-over-year from -$96458.8 in Q3 2024, and down 212.84% quarter-over-quarter from -$41604.0 in Q2 2025.
Aimei Health Technology (AFJK) EBITDA (2024 - 2025) Analysis & Trends
Aimei Health Technology (AFJK) has 2 years of EBITDA data on file, last reported at -$130152.0 in Q3 2025.
- EBITDA for Q3 2025 came in at -$130152.0, up 34.93% year-over-year; the trailing twelve-month figure through Sep 2025 was -$987191.0 (changed N/A YoY), and the FY2024 annual result was -$1.1 million, down 3641.47% from the prior year.
- EBITDA eased to -$130152.0 in Q3 2025 per AFJK's latest filing, from -$41604.0 in the prior quarter.
- Over five years, EBITDA peaked at -$41604.0 in Q2 2025 and troughed at -$413414.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -427,850.00 |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | -482,100.00 |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | -201,744.00 |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | -84,204.00 |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -1.15 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -225,545.00 |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | -198,194.00 |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 685,558.00 |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | -540,761.00 |
| 10 | Aimei Health Technology | 176.90 Mn | 176.90 Mn | - | -130,152.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -130,152.00 |
| Jun 30, 2025 | -41,604.00 |
| Mar 31, 2025 | -413,414.00 |
| Dec 31, 2024 | -402,021.00 |
| Sep 30, 2024 | -200,019.00 |
| Jun 30, 2024 | -309,114.00 |
| Mar 31, 2024 | -153,632.00 |